<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The attempts to develop new treatments for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> have been fraught with costly and spectacularly disappointing failures </plain></SENT>
<SENT sid="1" pm="."><plain>Repurposing of safe, older drugs provides a lower risk alternative </plain></SENT>
<SENT sid="2" pm="."><plain>Vascular protection is a novel strategy for improving <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome </plain></SENT>
<SENT sid="3" pm="."><plain>Promising targets for vascular protection after <z:hpo ids='HP_0001297'>stroke</z:hpo> have been identified, and several of these targets can be approached with "repurposed" old drugs, including <z:chebi fb="0" ids="35664">statins</z:chebi>, angiotensin receptor blockers (ARBs), and <z:chebi fb="1" ids="50694">minocycline</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>We tested the vascular protection (ability to reduce hemorrhagic transformation) of three marketed drugs (<z:chebi fb="0" ids="3347">candesartan</z:chebi>, <z:chebi fb="1" ids="50694">minocycline</z:chebi>, and <z:chebi fb="0" ids="39548">atorvastatin</z:chebi>) in the experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> model using three different rat strains [Wistar, spontaneously hypertensive rats (SHR) and type 2 diabetic Goto-Kakizaki (GK) rats] </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> agents decreased the <z:mpath ids='MPATH_124'>infarct</z:mpath> size, improved the neurological outcome and decreased <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Mechanisms identified include inhibition of MMP-9, activation of Akt, and increased expression of proangiogenic growth factors </plain></SENT>
<SENT sid="7" pm="."><plain>Premorbid vascular damage (presence of either <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0000822'>hypertension</z:hpo>) increased the likelihood of vascular injury after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion and improved the response to vascular protection </plain></SENT>
</text></document>